肉毒杆菌毒素市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00027431
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 197
Buy Now

肉毒毒素市场预计将从 2021 年的 53.0771 亿美元增至 2028 年的 89.7762 亿美元。预计 2021 年至 2028 年复合年增长率为 7.8%。

肉毒杆菌毒素是一种神经毒素,会攻击神经并导致肌肉麻痹。一种称为肉毒杆菌的细菌会产生这些神经毒素。医疗保健提供者使用特定细菌进行医疗注射。注射肉毒杆菌毒素会阻断注射到肌肉的神经信号。没有信号,肌肉就无法收缩。结果是减少了不需要的面部线条或特征。肉毒杆菌毒素注射(例如 Botox 和 Dysport)可通过放松引起皱纹的肌肉来改善外观。这些注射剂还可以治疗偏头痛、多汗症、膀胱过度活动症和眼部问题。

战略见解  


肉毒毒素市场分析产品类型、应用、最终用户和地理位置的基础。按地域划分,肉毒毒素市场大致分为北美、欧洲、亚太地区、中东和非洲 (MEA) 以及南美洲和中美洲。肉毒杆菌毒素报告提供了对市场的见解和深入分析,强调市场趋势、技术进步和市场动态等参数,以及对全球领先市场参与者的竞争格局的分析。      

肉毒毒素市场利润丰厚的区域


市场见解

越来越多的美容手术和肉毒杆菌毒素的使用推动了肉毒杆菌毒素市场的增长

法国各地的非手术程序和皮肤注射剂显着增加。根据全球美学共识,2016年,全国进行了约258,438例非手术美容手术,其中超过101,400例是肉毒杆菌毒素(BTX)手术。此外,美容诊所的扩张和美容从业人员数量的增加预计将在未来几年进一步推动肉毒杆菌毒素市场。由于法国先进的医疗服务,来自瑞士、罗马尼亚和俄罗斯等国家的人们前往法国进行美容手术。

此外,在意大利,每个人第10位申请整容手术的患者是一名游客。意大利美容整形外科协会(AICPE)宣布与国际美容整形外科协会(ISAPS)建立“美容联盟”,以开发高质量的美容手术,提高患者的安全性。这将增加肉毒杆菌毒素市场的需求。

同样,根据美国整形外科医生协会(ASPS)的数据,共有4,401,536例A型肉毒杆菌毒素(Botox、Dysport、Xeomin)微创美容手术在美国进行,其中女性 4,136,289 人,男性 265,247 人。 2020 年,美容神经网络 (ANN) 数据显示,美容整形手术的总收入超过 90 亿美元。同样,肉毒杆菌毒素市场的需求也将推动。

此外,根据美国整形外科医生协会(ASPS)的数据,2019年进行的整容手术数量印度为 643,752。非手术治疗总数为 249,024 例,其中肉毒杆菌毒素治疗为 70,248 例。同样,2019年巴西整容手术总数为2,565,675例,其中非手术手术总数为1,072,002例——其中肉毒杆菌毒素手术为507,869例,导致肉毒杆菌毒素市场不断增长。

< p> 

BTX 的治疗用途包括治疗慢性偏头痛、肌肉痉挛、膀胱过度反应和多汗症等疾病。 BTX 的美容和临床应用为美容手术和独立治疗以及联合治疗的医疗应用提供了全面和深入的回顾。根据 ISAPS 的数据,2018 年德国进行了约 321,702 例 BTX 手术。由于老年人口的增加和对看起来年轻的渴望,德国进行的基于 BTX 的手术数量正在增加。根据 ISAPS,德国约占全球整容手术总数的 4%。

此外,英国有超过 500 名整形外科医生,预计未来这一数字还会增加。因此,随着美容服务提供者、从业者和整形外科医生数量的增加,欧洲进行的美容手术数量不断增加,从而推动了肉毒杆菌毒素的需求和销售,促进了肉毒杆菌毒素市场的增长。

非侵入性整容手术数量的增加极大地促进了肉毒杆菌毒素市场的增长

整容手术和注射 BTX 是最流行的非侵入性嫩肤手术之一,每种手术都有其独特的改善面部美观的方法。 2020 年,BTX 治疗是欧洲领先的非侵入性美容手术。此外,在过去的十年中,面部年轻化手术在该地区不同类型的传统手术中很流行。在美容面部护理中使用 BTX A 型 (BoNTA) 有助于改善上脸和下脸的美观。因此,非侵入性整容手术的日益普及正在引发欧洲对肉毒杆菌毒素的需求。

根据美国整形外科医生协会 (ASPS) 的数据,2019 年按国家/地区划分的非手术手术< br>

资料来源:Insight Partners 分析、主要访谈、杂志和期刊以及二手资料

非侵入性美容治疗近年来,与开放式手术相比,由于其停机时间短、无疤痕、成本低、准确性更高且并发症更少,因此受到欢迎。此外,由于治疗后停机时间较短,非侵入性治疗变得越来越重要。欧洲国家正在采取多项举措来提高人们对非侵入性美容手术的认识。例如,2019 年,英国政府当局发起了一场关于拙劣整容手术及其对个人身心健康影响的运动。此外,一些制造商正在致力于提供更先进的非侵入性美容治疗产品。因此,人们对非侵入性美容手术的认识不断提高,以及用户友好且技术先进的非侵入性美容治疗产品的日益普及,正在推动欧洲肉毒毒素市场的增长。

产品类型洞察         ;   

根据产品类型,全球肉毒杆菌毒素市场分为A型肉毒杆菌毒素和B型肉毒杆菌毒素。 2020年,A型肉毒毒素细分市场占据肉毒毒素市场的最大份额。此外,A型肉毒毒素市场预计在2021年至2028年期间将以最高的复合年增长率增长。A型肉毒毒素注射剂用途广泛,安全性良好,是一种微创且有前景的治疗方法针对美容缺陷、肌肉痉挛和其他病症。 A 型肉毒杆菌毒素在治疗肌张力障碍、失禁、偏头痛、眼睑痉挛和多汗症方面有多种用途。根据制剂的不同,A 型肉毒杆菌毒素适用于不同的疾病。在美容上,它可以治疗脸上的细纹和皱纹,特别是上脸上的皱纹,包括前额、眼角和眉间纹。   

应用洞察

根据应用,肉毒毒素市场分为医疗和美容。医疗细分为慢性偏头痛、肌肉痉挛、膀胱过度反应、多汗症等。美容细分市场细分为眉间纹/眉间纹、额头纹、鱼尾纹、方下巴/咬肌等。

医疗细分市场拥有最大的市场预计到2020年将成为肉毒毒素市场的最大股东。肉毒毒素是一种用于治疗和管理多种治疗病症的药物。慢性偏头痛、痉挛性疾病、颈肌张力障碍和逼尿肌过度活跃都是药物用途的例子。神经毒素类药物需求的激增正在提振该细分市场。

最终用途见解

基于最终用户,肉毒杆菌毒素市场分为专科和皮肤科诊所、医院和诊所等。专科和皮肤科诊所在 2020 年占据了最大的市场份额,预计到 2028 年将成为市场的最大股东。微创技术的普及速度甚至比外科手术还要快。肉毒毒素(肉毒杆菌)注射、玻尿酸治疗、激光脱毛、非手术减脂和光子嫩肤(IPL)是2019年五种最常见的非手术美容手术,这支撑了该细分市场的肉毒毒素市场增长。

肉毒毒素市场,按产品类型划分 - 2021年和2028年

 

产品发布和并购是全球肉毒毒素市场参与者广泛采用的策略。以下列出了近期的一些关键产品开发:

  • 2021 年 8 月,Merz Therapeutics 获得 XEOMIN 用于 2 至 17 岁儿童和青少年慢性流涎症的对症治疗由于欧盟层面的神经/神经发育障碍。
  • 2020 年 12 月,Galderma 宣布 Alluzience 已完成其欧洲分散程序,从而对第一个即用型神经调节剂(一种皱纹松弛剂)做出了有利的决定注射,在欧洲。目前,整个地区的国家审批均按照每个国家的当地流程进行。

由于医疗机构关闭,COVID-19 大流行也对该地区的美容手术和肉毒杆菌毒素市场产生了重大影响。美国整形外科医生协会 (ASPS) 委员会认证的整形外科医生表示,2020 年,COVID-19 导致他们平均停止进行选择性外科手术 8.1 周,即一年中的 15%,反映出去年执行的程序总数有所下降。据美国整形外科医生协会 (ASPS) 称,COVID-19 大流行将导致 2020 年整容手术总数下降 15%,这与诊所关闭的时期大致一致——前五名手术中的三名都集中在面部。在 2020 年的居家订单期间,微创整容手术的下降幅度四年来首次略高于外科手术(分别为 16% 和 14%)。以下是 2020 年实施的前五名美容微创手术,总计 1330 万例:A 型肉毒杆菌毒素(440 万例手术)。除了 COVID-19 大流行之外,由于新批准的适应症、重复治疗的需要以及基本上有利的报销环境,预计该市场还将增长,从而导致手术量和肉毒杆菌毒素市场销售额的显着增加。

肉毒毒素市场 - 细分

肉毒毒素市场 - 按产品类型

  • A型肉毒杆菌毒素
  • B型肉毒杆菌毒素

肉毒杆菌毒素市场 - 按应用

  • 医疗
    • 慢性偏头痛
    • 肌肉痉挛
    • 膀胱过度反应
    • 多汗症
    • 其他
  • 审美
    • 鱼尾纹
    • 额头纹
    • 眉间纹/眉间
    • 方下巴/咬肌
    • 其他< /li>

肉毒毒素市场 - 按地理位置

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 英国
    • li>
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太地区其他地区
    • < /ul>
    • 中东和中东非洲 (MEA)
      • 沙特阿拉伯
      • 南非
      • 阿联酋
      • 中东其他地区和地区非洲
    • 南美洲和中美洲 (SCAM)
      • 巴西
      • 阿根廷
      • 中南美洲其他地区美国

    肉毒毒素市场公司简介

    • AbbVie Inc.
    • Merz Pharma
    • Merz Pharma
  • AbbVie Inc.
  • Merz Pharma
li>
  • Medytox
  • 赛诺菲
  • 益普森制药
  • 高德美
  • Revance Therapeutics Inc.
  • 兰州生物制品研究所有限公司
  • 坎德拉医疗
  • 大熊制药有限公司
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is a Botulinum Toxin?

    Botulinum toxins are neurotoxins that attack nerves and cause muscle paralysis. A bacterium known as clostridium botulinum makes these neurotoxins. Healthcare providers use specific bacteria for medical injections. Injections of botulinum toxin block nerve signals to the muscle injected into it. Without a signal, the muscle cannot contract. The result is a reduction in unwanted facial lines or features. Botulinum toxin injections like Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.

    What are the driving factors for the botulinum toxins market across the globe?

    Key factors that are driving the growth of this market are the increasing aesthetic procedures and use of botulinum toxin and rising number of noninvasive cosmetic procedures are expected to boost the market growth for the botulinum toxins over the years.

    What is the market CAGR value of the botulinum toxins market during the forecast period?

    The CAGR value of the botulinum toxins market during the forecasted period of 2021-2028 is 7.8%.

    Which product type led the botulinum toxins market?

    The type A botulinum toxin segment held the largest share of the market in the global botulinum toxins market in 2021.

    Who are the key players in the botulinum toxins market?

    The botulinum toxins market majorly consists of players such as AbbVie Inc., Merz Pharma, Medytox, Sanofi, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co., Ltd., Candela Medical, and Daewoong Pharmaceutical Co. Ltd. amongst others.

    Which are the top companies that hold the market share in the botulinum toxins market?

    AbbVie Inc. and Merz Pharma are the top two companies that hold huge market shares in the botulinum toxins market.

    Which region is expected to witness significant demand for the botulinum toxins market in the coming years?

    Global botulinum toxins market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share for botulinum toxins in 2021. The United States held the largest market in North America for botulinum toxins, and the market is expected to grow due to the rising aesthetic procedures, and growing development of non-invasive aesthetic procedures are projected to accelerate the growth of the botulinum toxins market.

    The List of Companies - Botulinum Toxin Market

    1. AbbVie Inc.
    2. Merz Pharma
    3. Medytox
    4. Sanofi
    5. Ipsen Pharma
    6. Galderma
    7. Revance Therapeutics Inc.
    8. Lanzhou Institute of Biological Products Co., Ltd.
    9. Candela Medical
    10. Daewoong Pharmaceutical Co., Ltd.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports